Errico, F.; Marino, C.; Grimaldi, M.; Nuzzo, T.; Bassareo, V.; Valsecchi, V.; Panicucci, C.; Di Schiavi, E.; Mazza, T.; Bruno, C.;
et al. Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy. Biomolecules 2022, 12, 1431.
https://doi.org/10.3390/biom12101431
AMA Style
Errico F, Marino C, Grimaldi M, Nuzzo T, Bassareo V, Valsecchi V, Panicucci C, Di Schiavi E, Mazza T, Bruno C,
et al. Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy. Biomolecules. 2022; 12(10):1431.
https://doi.org/10.3390/biom12101431
Chicago/Turabian Style
Errico, Francesco, Carmen Marino, Manuela Grimaldi, Tommaso Nuzzo, Valentina Bassareo, Valeria Valsecchi, Chiara Panicucci, Elia Di Schiavi, Tommaso Mazza, Claudio Bruno,
and et al. 2022. "Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy" Biomolecules 12, no. 10: 1431.
https://doi.org/10.3390/biom12101431
APA Style
Errico, F., Marino, C., Grimaldi, M., Nuzzo, T., Bassareo, V., Valsecchi, V., Panicucci, C., Di Schiavi, E., Mazza, T., Bruno, C., D’Amico, A., Carta, M., D’Ursi, A. M., Bertini, E., Pellizzoni, L., & Usiello, A.
(2022). Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy. Biomolecules, 12(10), 1431.
https://doi.org/10.3390/biom12101431